Epidemiology Practice Questions

Q: Which of the following is FALSE regarding the case fatality rate?

The denominator is the mid-year population.. ### Explanation **1. Why Option B is the Correct Answer (False Statement):** The **Case Fatality Rate (CFR)** is defined as the proportion of people diagnosed with a specific disease who die from that disease within a specified period. * **Formula:** (Total number of deaths due to a disease / Total number of cases of that disease) × 100. * The denominator is the **total number of cases**, not the mid-year population. * The **mid-year population** is used as the denominator for the **Crude Death Rate (CDR)** or **Cause-Specific Mortality Rate**, which are true rates. CFR, despite its name, is technically a **ratio/proportion**. **2. Analysis of Other Options:** * **Option A & C:** These are true. CFR measures the **virulence** of an organism and the **killing power** (severity) of a disease. A high CFR (e.g., Rabies ~100%) indicates a highly virulent pathogen. * **Option D:** This is true. CFR is most useful for **acute infectious diseases** (e.g., Cholera, Ebola) where the outcome (death or recovery) occurs quickly. In chronic diseases (e.g., Diabetes, Hypertension), the long duration makes it difficult to link death directly to the initial diagnosis in a simple ratio. ### High-Yield Clinical Pearls for NEET-PG: * **CFR vs. Mortality Rate:** Mortality rate uses the *entire population at risk* as the denominator; CFR uses only *confirmed cases*. * **Complement of CFR:** (100 - CFR) represents the **Survival Rate**. * **Disease with highest CFR:** Rabies (virtually 100%). * **Relationship with Virulence:** Virulence is the ability of an infectious agent to cause severe disease or death, measured specifically by the Case Fatality Rate. * **Time Sensitivity:** CFR can vary based on the quality of treatment, early detection, and host immunity.

Q: All of the following are measures of mortality except?

Incidence. **Explanation:** The core of this question lies in distinguishing between measures of **mortality** (death) and measures of **morbidity** (sickness/occurrence). **Why Incidence is the Correct Answer:** **Incidence** is defined as the number of *new cases* of a specific disease occurring in a defined population during a specific period. It is a measure of **morbidity**. It reflects the rate at which healthy people develop a disease, focusing on the occurrence of the condition rather than the outcome of death. **Analysis of Incorrect Options (Mortality Measures):** * **Crude Death Rate (CDR):** This is the most common mortality indicator. It measures the number of deaths per 1,000 mid-year population in a given year. * **Survival Rate:** This is the proportion of survivors in a group (e.g., a 5-year survival rate for cancer). It is mathematically the complement of the mortality rate and is used to describe the prognosis and fatality of a disease. * **Case Fatality Rate (CFR):** This represents the killing power of a disease. It is the proportion of deaths among diagnosed cases of a specific disease. It is a key indicator of disease severity and the effectiveness of treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence vs. Incidence:** Remember that Prevalence = Incidence × Mean Duration of disease ($P = I \times D$). * **CFR vs. Mortality Rate:** CFR is a proportion (not a true rate), whereas Crude Death Rate is a true rate. * **Standardized Mortality Ratio (SMR):** A high-yield concept often tested alongside these; it is the ratio of observed deaths to expected deaths, expressed as a percentage. * **Case Fatality Rate** is the best indicator of the **virulence** of an infectious agent.

Q: A drug that reduces mortality but does not cure a disease will gradually lead to which of the following?

Increase in prevalence with no change in incidence. ### Explanation The relationship between incidence, prevalence, and duration of a disease is defined by the formula: **Prevalence (P) = Incidence (I) × Mean Duration (D)** #### 1. Why Option A is Correct * **Incidence:** This refers to the number of **new cases** occurring in a population. A drug that reduces mortality or improves survival does not prevent the disease from occurring; therefore, the incidence remains unchanged. * **Prevalence:** This refers to the **total number of existing cases** (old + new). When a drug prevents death but does not provide a cure, patients live longer with the disease. This increases the **duration (D)** of the illness. Since Prevalence is a product of Incidence and Duration, an increase in duration directly leads to an increase in prevalence. #### 2. Why Other Options are Wrong * **Option B & D:** These are incorrect because the drug described does not affect the risk factors or the rate at which new cases develop. Therefore, **Incidence cannot increase** based on the drug's mechanism of reducing mortality. * **Option C:** This would occur if a drug were **preventive** (decreasing incidence) and **curative** (decreasing prevalence by shortening duration). #### 3. NEET-PG High-Yield Pearls * **Prevalence $\approx$ I × D:** This formula is valid only when the incidence and duration are stable (Steady State). * **Factors increasing Prevalence:** Better reporting/diagnosis, prolongation of life (without cure), and in-migration of cases. * **Factors decreasing Prevalence:** High case-fatality rate (quick death), high cure rate, and out-migration of cases. * **Incidence** is the best indicator for controlling acute outbreaks and studying the etiology (causation) of a disease.

Q: 91-96% of polio virus infections cause which of the following?

Subclinical infection. In Polio epidemiology, the clinical spectrum is often described as an **"iceberg phenomenon,"** where the vast majority of cases remain hidden below the surface. ### **Explanation of the Correct Answer** **A. Subclinical infection:** In approximately **91–96%** of cases, Poliovirus infection is entirely asymptomatic (subclinical). The virus replicates in the gut and is excreted in the feces, inducing immunity without causing any clinical symptoms. These individuals act as the primary reservoirs for spreading the virus in the community. ### **Explanation of Incorrect Options** * **B. Abortive polio (Minor Illness):** This occurs in about **4–8%** of infections. It presents as a non-specific viral syndrome (fever, malaise, sore throat) without neurological involvement. * **C. Non-paralytic polio:** This occurs in about **1%** of cases. It presents as aseptic meningitis with symptoms like neck stiffness and back pain, but without subsequent paralysis. * **D. Paralytic polio:** This is the rarest manifestation, occurring in **less than 1%** (roughly 0.1% to 0.5%) of infections. It involves the destruction of anterior horn cells, leading to asymmetrical flaccid paralysis. ### **High-Yield Clinical Pearls for NEET-PG** * **The Ratio:** For every 1 paralytic case in children, there are roughly 200–1000 subclinical cases (the "hidden" part of the iceberg). * **Infectivity:** Maximum infectivity occurs during the late incubation period and the first week of symptoms. * **Reservoir:** Man is the only reservoir; there are no chronic carriers. * **Specimen of Choice:** For diagnosis of a suspected case, **stool samples** are preferred over throat swabs as the virus is excreted in feces for several weeks.

Q: Case fatality rate is a method of measuring which epidemiological parameter?

Virulence. **Explanation:** **1. Why Virulence is the Correct Answer:** Virulence refers to the degree of pathogenicity or the **severity of the disease** produced by an infectious agent. It is quantitatively measured by the **Case Fatality Rate (CFR)**, which is the proportion of diagnosed cases of a specific disease that result in death. * **Formula:** $CFR = \frac{\text{Total deaths from a disease}}{\text{Total diagnosed cases of the same disease}} \times 100$ A high CFR indicates a highly virulent organism (e.g., Rabies has a CFR of nearly 100%, indicating extreme virulence). **2. Why Other Options are Incorrect:** * **A. Infectivity:** This measures the ability of an agent to enter, survive, and replicate in a host. It is measured by the **Secondary Attack Rate (SAR)**. * **B. Pathogenicity:** This is the ability of an infectious agent to produce clinically apparent disease in an exposed population. It is measured by the ratio of **clinical cases to the total number of infected persons**. * **D. Average duration of disease:** This is a temporal parameter used to calculate Prevalence ($P = I \times D$). It is not measured by mortality ratios. **3. High-Yield NEET-PG Pearls:** * **Virulence vs. Pathogenicity:** Pathogenicity asks "Can it make you sick?"; Virulence asks "How sick/dead does it make you?" * **CFR and Outbreaks:** CFR is a primary marker for the killing power of an acute infectious disease outbreak. * **Numerator/Denominator Tip:** In CFR, both the numerator and denominator come from the **same disease population**, unlike the Crude Death Rate, which uses the total mid-year population. * **Exception:** CFR is not useful for chronic diseases (e.g., Diabetes) because the "duration of disease" is long and the link to immediate death is less direct.

Q: What is false about case fatality rate?

It is not useful for acute diseases. ### Explanation **Case Fatality Rate (CFR)** is defined as the proportion of cases of a specified disease which are fatal within a specified time. It is calculated as: $\text{CFR} = \frac{\text{Total deaths from a disease}}{\text{Total diagnosed cases of that disease}} \times 100$ #### Why Option B is the Correct Answer (The False Statement) CFR is **highly useful for acute diseases** (e.g., Cholera, Ebola, Meningococcal meningitis). In acute conditions, the outcome (death or recovery) occurs quickly, allowing for a clear calculation of the disease's killing power. Therefore, stating it is "not useful" for acute diseases is incorrect. #### Analysis of Other Options * **Option A (It is a ratio):** While the name says "rate," mathematically it is a **ratio** (specifically a proportion), as the numerator is a part of the denominator and it is expressed as a percentage. * **Option C (It is related to virulence):** CFR is the primary clinical measure of the **virulence** of a pathogen. A higher CFR indicates a more virulent strain or a more severe disease process. * **Option D (It is not useful in chronic diseases):** This is a **true** statement. In chronic diseases (e.g., Diabetes, Hypertension), the duration of the illness is long and patients often die from comorbidities rather than the primary disease itself, making CFR an unreliable measure. #### High-Yield NEET-PG Pearls * **CFR vs. Mortality Rate:** Mortality rate uses the *total population at risk* as the denominator, whereas CFR uses only *confirmed cases*. * **Complement of CFR:** (100 - CFR) represents the **Survival Rate**. * **Time Frame:** CFR must always be linked to a specific time period (e.g., "The 5-year CFR for Breast Cancer"). * **Selection Bias:** CFR can be falsely high if only hospitalized (severe) cases are counted, missing subclinical or mild cases.

Q: Cluster testing is done in which of the following conditions?

AIDS. **Explanation:** The correct answer is **AIDS (Option B)**. **Cluster Testing** (also known as Social Network Testing) is a targeted case-finding strategy used primarily for HIV/AIDS and other STIs. In this method, a person diagnosed with HIV (the "index case") is asked to identify individuals in their social, sexual, or drug-using network who may have been exposed to the virus. These "clusters" of high-risk individuals are then offered counseling and testing. This approach is highly effective for AIDS because the disease often concentrates within specific high-risk groups (MSM, IDUs, FSWs), and social networks are strong predictors of risk. **Why other options are incorrect:** * **Malaria:** Case detection is done through **Active Surveillance** (house-to-house visits by health workers to find fever cases) and **Passive Surveillance** (patients reporting to clinics). * **TB:** The primary strategy is **Passive Case Finding** (testing symptomatic individuals who visit health facilities). While contact tracing is done for household members, "cluster testing" as a specific epidemiological term is not the standard nomenclature for TB screening. * **Pneumonia:** This is generally managed through clinical diagnosis and IMNCI protocols in community settings; it does not follow a cluster-based epidemiological testing model. **High-Yield Pearls for NEET-PG:** * **Mass Screening:** Used when the disease is common and the test is cheap (e.g., Hypertension, Diabetes). * **High-risk Screening:** Targeted at those with specific risk factors (e.g., Cluster testing in AIDS). * **Sentinel Surveillance:** Used to identify "missing cases" and supplement notifications to estimate the true burden of disease (commonly used in HIV). * **Contact Tracing:** Most critical in STIs and highly infectious diseases like COVID-19 or Ebola.

Question 1

Which of the following is FALSE regarding the case fatality rate?

Accepted Answer

The denominator is the mid-year population.

Answer

It represents the killing power of a disease.

Answer

It indicates the virulence power of the causative agent.

Answer

It is not very useful for chronic diseases.

Question 2

All of the following are measures of mortality except?

Accepted Answer

Incidence

Answer

Crude death rate

Answer

Survival rate

Answer

Case fatality rate

Question 3

A drug that reduces mortality but does not cure a disease will gradually lead to which of the following?

Accepted Answer

Increase in prevalence with no change in incidence

Answer

Increase in incidence and decrease in prevalence

Answer

Decrease in incidence and prevalence

Answer

Increase in incidence and prevalence

Question 4

91-96% of polio virus infections cause which of the following?

Accepted Answer

Subclinical infection

Answer

Above polio

Answer

Non-paralytic polio

Answer

Paralytic polio

Question 5

What criterion is used to declare an area as free of an epidemic?

Accepted Answer

No new case reported for twice the incubation period of the disease since the last case

Answer

No new case reported for the incubation period of the disease since the last case

Answer

Till the last secondary case recovers

Answer

No new case reported for six months since the last case

Question 6

Case fatality rate is a method of measuring which epidemiological parameter?

Accepted Answer

Virulence

Answer

Infectivity

Answer

Pathogenicity

Answer

Average duration of disease

Question 7

What is false about case fatality rate?

Accepted Answer

It is not useful for acute diseases

Answer

It is a ratio

Answer

It is related to virulence

Answer

It is not useful in chronic diseases

Question 8

Bias due to wrong interpretation of laboratory test results in inter-observer variation is?

Accepted Answer

Observation bias

Answer

Selection bias

Answer

Sampling bias

Answer

Recall bias

Question 9

Cluster testing is done in which of the following conditions?

Accepted Answer

AIDS

Answer

Malaria

Answer

TB

Answer

Pneumonia

Question 10

Which of the following is NOT a characteristic of causal association?

Accepted Answer

Sensitivity

Answer

Coherence

Answer

Specificity

Answer

Biological plausibility

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?